Drug Shortage Report for APIDRA

Last updated on 2021-11-24 History
Report ID 149719
Drug Identification Number 02294346
Brand name APIDRA
Common or Proper name Apidra Solostar
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN GLULISINE
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 5
ATC code A10AB
ATC description INSULINS AND ANALOGUES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2021-11-19
Estimated end date 2021-12-03
Actual end date 2021-11-23
Shortage status Resolved
Updated date 2021-11-24
Company comments Transporation Delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2021-11-24 English Compare
v4 2021-11-23 French Compare
v3 2021-11-23 English Compare
v2 2021-11-22 French Compare
v1 2021-11-22 English Compare

Showing 1 to 5 of 5